. Postexercise proteincarbohydrate and carbohydrate supplements increase muscle glycogen in men and women. J. Appl. Physiol. 83(6): 1877-1883.-We have previously demonstrated that women did not increase intramuscular glycogen in response to an increased percent of dietary carbohydrate (CHO) (from 60 to 75% of energy intake) (M. A. Tarnopolsky, S. A. Atkinson, S. M. Phillips, and J. D. MacDougall. J. Appl. Physiol. 78: 1360-1368. CHO and CHO-protein (Pro) supplementation postexercise can potentiate glycogen resynthesis compared with placebo (K. M. Zawadzki, B. B. Yaspelkis, and J. L. Ivy. J. Appl. Physiol. 72: 1854-1859 , 1992 . We studied the effect of isoenergetic CHO and CHO-Pro-Fat supplements on muscle glycogen resynthesis in the first 4 h after endurance exercise (90 min at 65% peak O 2 consumption) in trained endurance athletes (men, n ϭ 8; women, tested in midfollicular phase, n ϭ 8). Each subject completed three sequential trials separated by 3 wk; a supplement was provided immediately and 1-h postexercise: 1) CHO (0.75 g/kg) ϩ Pro (0.1 g/kg) ϩ Fat (0.02 g/kg), 2) CHO (1 g/kg), and 3) placebo (Pl; artificial sweetener). Subjects were given prepackaged, isoenergetic, isonitrogenous diets, individualized to their habitual diet, for the day before and during the exercise trial. During exercise, women oxidized more lipid than did men (P Ͻ 0.05). Both of the supplement trials resulted in greater postexercise glucose and insulin compared with Pl (P Ͻ 0.01), with no gender differences. Similarly, both of these trials resulted in increased glycogen resynthesis (37.2 vs. 24.6 mmol · kg dry muscle Ϫ1 ·h Ϫ1 , CHO vs. CHO-Pro-Fat, respectively) compared with Pl (7.5 mmol · kg dry muscle Ϫ1 ·h Ϫ1 ; P Ͻ 0.001) with no gender differences. We conclude that postexercise CHO and CHO-Pro-Fat nutritional supplements can increase glycogen resynthesis to a greater extent than Pl for both men and women.
gender; sex differences; defined formula; exercise THE TIMING of the provision of nutrients after exercise has become a popular subject in recent years (3, 11, 26) . It is known that carbohydrate (CHO) supplements provided within the first several minutes of completion of exercise result in a more rapid repletion of muscle glycogen compared with the same supplement provided 2 h after completion of exercise (11) . The mechanism responsible for this observation is thought to be related to the combined effect of insulin and contractionstimulated glucose transport via GLUT-4 transporters (6) . The migration of these transporters from intracellular stores to the sarcolemma and t tubules of muscle is partially mediated by phosphatidylinositol 3-kinase (8) . The practical implication of these findings is that it may be possible to accentuate glycogen repletion by merely altering the timing of nutrient provision (i.e., providing nutrients shortly after exercise termination).
It has been suggested that a combination protein (Pro) and CHO supplement provided immediately postexercise may potentiate insulin release and, hence, glycogen repletion (26) . For example, Zawadzki and colleagues (26) found that the insulin rise and glycogen repletion rate was 39% greater with a combined Pro-CHO compared with a CHO supplement. The confounding factor in this latter study was the provision of 43% more energy in the Pro-CHO trial compared with the CHO trial; thus two variables changed simultaneously. Therefore, one purpose of the present study was to compare the rate of glycogen resynthesis after endurance exercise when the energy content of both the postexercise supplement (CHO compared with CHOPro-Fat) and the 24-h energy intake of all trials was held constant.
In addition, almost all of the research that has been conducted to examine postexercise supplements has used male subjects exclusively (5, 11, 26) . Aside from the inherent gender bias, there is also accumulating evidence that there are sex differences in the metabolic response to endurance exercise (22) (23) (24) . These differences may be related to our recent finding that men, but not women, increase muscle glycogen concentration in response to an increase in dietary CHO content from 60 to 75% of energy intake (21) . Therefore, a second purpose of this study was to examine postexercise glycogen repletion in both sexes.
We had three a priori hypotheses. 1) There would be no difference in the rate of glycogen repletion between CHO and CHO-Pro-Fat supplements, yet there would be a greater rate of glycogen repletion compared with placebo (Pl).
2) The glycogen repletion rate for women would be less than that observed in men. 3) Women would have a lower respiratory exchange ratio (RER) during endurance exercise (indicative of greater lipid oxidation).
METHODS
Subjects. Two groups of male (n ϭ 8) and female (n ϭ 8) athletes volunteered for the study. The study was approved by the McMaster University Human Ethics Committee, and written informed consent was obtained after the experimental procedures, risks, and benefits were explained to each subject.
Men were recruited who had a peak O 2 consumption (V O 2 peak ) of at least 55 ml · kg Ϫ1 · min Ϫ1 . Women were matched to the men by training history and required a V O 2 peak of at least 50 ml · kg Ϫ1 · min Ϫ1 . Equalized matching based on these parameters was confirmed by the similarity in V O 2 peak when expressed per kilogram lean mass (Table 1 ).
All female subjects were eumenorrheic for at least 6 mo before testing, and three were taking oral contraceptives. The women were tested during the midfollicular phase of their menstrual cycle. This phase was chosen for a more accurate ability to determine the onset of the follicular phase (day 1 of menses) compared with the luteal phase (ovulation) and also for comparison with our previous work (17, 22) .
Design. The subjects participated in a Pl-controlled, doubleblind three-part trial. Trial 1, CHO-Pro-Fat, was 66% CHO, 23% Pro, 11% Fat. Specifically, CHO ϭ 56% sucrose and 46% glucose polymer from corn syrup solids; Pro ϭ milk protein; Fat ϭ canola, sunflower, and corn oil, with vitamins, minerals, and flavoring (commercially available sports drink, MeadJohnson, Canada). Trial 2, a CHO-only trial, included 100% CHO, as described above. Trial 3 used, as a Pl, Sucralose (sucrose derivative not recognized as CHO by the body, as well as vitamins, minerals, and flavoring). Each subject completed all three trials with 3-4 wk separating each trial. Each trial was 5 days in length and was identical in terms of exercise, diet timing, and prescription (see Experimental protocol). The trial sequence was randomly chosen. However, because of an error by the technician who blinded the study, all subjects participated in each trial in the same sequence [i.e., all subjects received the supplements in the same order listed above, yet both they and the other investigators were blinded to the supplement allocation (double blind)].
Within 2 wk of the experimental trials, V O 2 peak was determined on an electrically braked cycle ergometer by using a computerized open-circuit gas-collection system as previously described (17) . V O 2 peak was considered to be the highest value recorded during a standard incremental cycle ergometer protocol, with termination of the test after O 2 consumption (V O 2 ) values reached a plateau for three readings, RER was Ͼ1.12, and subjects could not sustain pedal revolutions at ϳ60 revolutions/min (rpm) despite vigorous encouragement. Body density was determined by hydrostatic weighing, and percent body fat was calculated as described (17) .
All subjects collected 4-day diet records, which were analyzed by using a nutritional analysis software package (Nutritionist IV; First Data Bank, San Bruno, CA). For each subject, individual diets were designed that were both isoenergetic and isonitrogenous for the three trials. The only parameter that was different was the composition of the postexercise supplement on day 1 (practice day) and day 5 (test day). For example, on the Pl-testing trial, the Pl drink was given postexercise and a CHO-Pro-Fat supplement was provided with supper. The reverse was true for the CHO-Pro-Fat trial; namely, the Pl supplement was provided with supper. For the CHO trial, a Pro-Fat supplement was provided with supper (Table 2) . Thus, over a 24-h period, the energy and nutritional composition of each trial was identical (Table 3) . Diets were rigidly controlled over the 5-day experimental protocol for each of the three trials. Subjects were instructed to eat only the prepackaged diets provided on days 1, 4, and 5. Individual checklist diets were followed on the alternate days (days 2 and 3). Compliance was assessed by analyzing the diet checklists that were returned by each subject. Furthermore, on the days when food was prepackaged, they returned any uneaten food for weighing. The apparent energy intake compliance was Ͼ96% of that distributed.
Experimental protocol. During each 5-day experimental period, subjects adhered to the postexercise regimen to simulate a typical training schedule: on days 1 and 5, subjects exercised on a cycle ergometer at a power output preset to elicit 65% of V O 2 peak for 90 min. Day 1 was designed as a controlled trial practice session in preparation for day 5 and was performed in the evening (from 1700 to 2000), with postexercise supplements identical to that described below for day 5. No exercise was performed in the 24 h before each of these testing days. On day 2, subjects arrived at the laboratory in a fasted state (at 0700-0900) and performed a high-intensity ride to exhaustion at a preset load designed to elicit 75% of V O 2 peak . The ride was terminated when subjects could not sustain pedal revolutions of Ͼ60 rpm. Subjects cycled for 45 min at 65% of V O 2 peak on day 3 and rested on day 4.
On day 5, subjects arrived in a fasted state (at 0700-0900), and a 22-gauge plastic catheter was inserted into the antecubital vein for blood sampling. Blood samples were then collected into prechilled, heparinized tubes every 30 min during exercise and every 20 min up to 2 h postexercise. Additional samples were collected at 3 and 4 h postexercise, and the catheter was then removed. These tubes were centrifuged immediately, and aliquots of plasma were stored at Ϫ50°C for subsequent analysis of glucose and insulin.
After the exercise was completed, a muscle biopsy was obtained from the vastus lateralis by using a suction-modified Bergstrom needle-biopsy technique. A supplement (CHO-ProFat in trial 1, CHO in trial 2, and Pl in trial 3) was given immediately after the muscle biopsy [time 0 (t ϭ 0)] and at 1 h (t ϭ ϩ1) after the first supplement. A second needle biopsy was performed on the contralateral vastus lateralis 4 h after the first supplement (t ϭ ϩ4). All biopsy samples were blotted and dissected free of visible connective tissue, quenched in liquid nitrogen, and then stored at Ϫ50°C for later analysis of muscle glycogen.
During each trial, 24-h urine collections were completed over day 4 (rest) and day 5 (exercise). Aliquots were taken and stored at Ϫ50°C for subsequent analysis of creatinine and total urea nitrogen. Plasma and urine. All plasma samples were assayed for insulin by radioimmunoassay (Diagnostics Products, Los Angeles, CA). Glucose was determined by spectrophotometry (kit 135, Sigma Diagnostics, St. Louis, MO). Intra-assay coefficient of variation for glucose and insulin was Ͻ5%.
Rest and exercise 24-h urine collections were assayed by using spectrophotometry to determine urea nitrogen (procedure 640, Sigma Diagnostics) and urine creatinine (kit 555-A, Sigma Diagnostics).
Muscle glycogen analysis. Before analysis, the muscle samples were lyophilized and powdered, and any visible remaining blood or connective tissue was removed before weighing. Glycogen concentration was determined by a method adapted from that described by Bergmeyer (1). Briefly, 160 µl of NaOH were added to ϳ2.0-4.0 mg of dry muscle (dm) tissue and mixed thoroughly. After incubation at 80°C for 10 min, 640 µl of a combined acid-buffer solution (HClcitrate) were added to neutralize the sample. Then 40 µl of a reagent solution were added [in mM: 375 triethanolamine, 150 KOH, 112.5 Mg(Ac) 2 Calculations. Muscle glycogen resyntheses rate was calculated from the equation: Rate ϭ (G post Ϫ G pre )/t, where G pre is the muscle glycogen concentration immediately postexercise, G post is the muscle glycogen concentration 4 h postexercise, and t is the time between the two biopsies.
Statistics. Muscle and blood data were analyzed by using repeated-measures analysis of variance (gender ϫ time ϫ condition) (version 5.0 Statistica, Statsoft, Tulsa, OK). When a significant interaction was found, Tukey's post hoc analysis was used to locate the pairwise differences. Integrated area under the curve data for glucose and insulin was analyzed by using a one-way repeated-measures analysis of variance (version 5.0 Statistica). P Ͻ 0.05 was accepted as statistical significance. Values are expressed as means Ϯ SD.
RESULTS

Substrate oxidation.
The RER values over the 90 min of exercise were significantly lower for women compared with men for all three trials (CHO-Pro-Fat: 0.902 Ϯ 0.04 vs. 0.934 Ϯ 0.03, women vs. men, respectively; CHO: 0.882 Ϯ 0.04 vs. 0.902 Ϯ 0.03, women vs. men, respectively; Pl: 0.896 Ϯ 0.03 vs. 0.918 Ϯ 0.02, women vs. men, respectively; P Ͻ 0.005). There were no significant gender or time differences in V O 2 or heart rate for any of the three trials (Table 4 ). There were no differences between the trials in 24-h urea nitrogen or creatinine. There was a trend for 24-h urea nitrogen and creatine to be greater on the exercise day compared with the rest day [not significant (NS)]. There were no differences between men and women in 24-h urea nitrogen and creatinine. The total energy cost of the 90-min exercise bout at 65% V O 2 peak for the men was 1,214, 1,198, and 1,214 kcal for the CHO-Fat/Pro, CHO, and Pl trials, respectively. Similarly, the total energy cost for the women at 65% V O 2 peak was 910, 899, and 963 kcal for the CHO-Fat/Pro, CHO, and Pl trials, respectively. Lipid contributed to ϳ29% of the total energy cost for the women and 23% for the men of the 90-min exercise bout over the three trials (P Ͻ 0.005). CHO contributed 75% of the energy cost of the three trials for the men and 68% for the women (P Ͻ 0.005). Pro contributed 2% to the energy cost of the 90 min of exercise for the men and 3% for the women (NS; calculated from RER and urea by using equations from Ref.
9).
Insulin and glucose. There were no differences in plasma insulin concentrations between the trials at the beginning of exercise, at the end of exercise, and at the time of the second biopsy. Plasma insulin concentrations were significantly higher for the CHO-Pro-Fat vs. the Pl condition at the time points 20, 40, 60, 80, and 120 min postexercise ( Fig. 1B; P Ͻ 0.01) . Similarly, the CHO condition significantly elevated plasma insulin concentrations at 20, 40, 60, 80, 100, and 120 min postexercise compared with the Pl (P Ͻ 0.01). The total integrated area under curve for insulin was significantly greater for both the CHO-Pro-Fat trial (about threefold) and the CHO trial (about fourfold) vs. the Pl trial (21.66 vs. 26.2 vs. 6.34 µIU · l Ϫ1 ·h Ϫ1 in CHO-ProFat vs. CHO vs. Pl trials, respectively; P Ͻ 0.01). There were no significant differences between men and women.
There were no differences between the three trials in plasma glucose concentration at baseline or during exercise. The CHO trial resulted in significantly higher plasma glucose at 40, 60, 80, 100, and 120 min compared with the Pl trial (P Ͻ 0.01; Fig. 1A) . The CHO-Pro-Fat trial resulted in an increase in glucose vs. the Pl trial, although only the 40-min time point was statistically significant (P Ͻ 0.05). The area under the glucose curve was not statistically different between the CHO-Pro-Fat and the CHO trial (4.75 vs. 5.35 mM/h, respectively) but these were both greater than the Pl trial (4.06 mM/h; P Ͻ 0.05; Fig. 1A, right) . There were no significant differences between men and women.
Glycogen. The rates of postexercise muscle glycogen recovery for both the CHO-Pro-Fat and the CHO trials were significantly higher (P Ͻ 0.05) compared with the Pl trials [in mmol · kg dm Ϫ1 ·h Ϫ1 (men vs. women, respectively): CHO-Pro-Fat, 25.5 vs. 23.5; CHO, 40.0 vs. 34.5; Pl, 3.0 vs. 12.0]. There were no significant differences in muscle glycogen recovery rates between men and women for any of the three trials (Fig. 2) . For both the CHO-Pro-Fat and the CHO trials, the muscle glycogen concentration was significantly higher (P Ͻ 0.001) at t ϭ ϩ4 h compared with the immediate postexercise time point (t ϭ 0) (CHO-Pro-Fat, from 142.4 Ϯ 69 to 245.2 Ϯ 75 mmol/kg dm; CHO, from 163.4 Ϯ 53.6 to 312.8 Ϯ 56 mmol/kg dm). The Pl trial did not result in an increased muscle glycogen concentration after 4 h (from 210 Ϯ 68 to 237 Ϯ 80 mmol/kg dm; NS). Post hoc analysis demonstrated that the glycogen concentration at t ϭ 0 was greater for the Pl trial compared with the CHO-Pro-Fat and CHO trials (P Ͻ 0.01).
DISCUSSION
We have demonstrated that postexercise muscle glycogen resynthesis rates are similar for both CHO and isoenergetic CHO-Pro-Fat supplements and that both of these are greater than for a Pl. Contrary to our other hypothesis, the resynthesis rate was similar for men and women.
Some have questioned the practical value of postexercise supplements because of the observation that muscle glycogen concentrations were not different 8 and 24 h after exercise cessation when CHO was provided immediately or after a 2-h time delay (16) . However, there are several examples where early postexercise supplementation may be of practical benefit: 1) when an athlete is training or competing more than once per day, 2) when an athlete exercises in the evening on one day and again the next morning, and 3) when an athlete may not be able to consume a high-CHO diet over the ensuing 24-h postexercise period.
The finding of similar postexercise insulin responses with different supplements is consistent with some (5, 18a) but not all (21, 26) studies. Zawadzki and colleagues (26) found that plasma insulin concentrations and glycogen resynthesis rates were greater for CHOPro compared with CHO supplements. However, it is not possible to separate the cointervention of added energy intake (ϩ43%) from the macronutrient compositional changes in their study (26) . Our finding of no difference in glycogen resynthesis between isoenergetic CHO and CHO-Pro-Fat supplements suggests that energy intake may have contributed to the observations in the latter study (26) . The finding of similar insulin and glucose responses was also confirmed in other studies where isoenergetic CHO and CHO-Pro (5) and CHO-Pro-Fat (unpublished observations by B. D. Roy and M. A. Tarnopolsky) were compared after resistance exercise. It may be argued that the minimal fat content of the supplement used in our study may have confounded the results by inhibiting gastric emptying and, thus, potentially inhibiting the rapid provision of CHO to the muscle and CHO-Pro to the pancreas for insulin release. We do not feel that gastric inhibition was a factor, because insulin rose rapidly in the CHO-Pro-Fat trial and was not statistically different from the CHO trial at any time after the supplement. Furthermore, over a 24-h period after endurance exercise, the addition of similar amounts of fat to the diet did not impair glycogen resynthesis in a study of eight well-trained endurance athletes (3). The CHO source used in the current study was sucrose (contains fructose) and glucose polymers rather than glucose in the study by Zawadzki et al. (26) . However, there were very similar insulin responses observed in Zawadzki's study (26) compared with the present study. Thus it is unlikely that this could have altered the results. Furthermore, the most important comparison in the present study was that between the CHO and CHO-ProFat trial, and the CHO source was identical in these.
It could also be argued that the order of the trials in our study could have influenced the results. However, we found no difference between the trials in V O 2 , heart rate, RER, insulin, or glucose during exercise. Because we studied trained endurance athletes who were accustomed to this training intensity and we separated the trials by nearly 1 mo, a training effect would be further negated. However, the postexercise glycogen concentration was significantly greater for the Pl trial compared with the other trials because of two outliers (1 in each gender). These subjects were predominantly runners, and it is possible that they developed a more efficient cycling form in subsequent trials. A greater reliance on the gastrocnemius and hamstrings (by use of toeclips) would reduce the work of the quadriceps muscles. Lower glycogen concentrations can result in greater glycogen resynthesis rates per se (18, 27) . However, this difference is only significant when muscle glycogen concentrations are Ͻ120 mmol/kg dm (18) . The 27% difference in glycogen concentration between the two supplement trials compared with the Pl trial fell within the range (120-280 mmol/kg dm) that has been shown to have no effect on glycogen resynthesis rates (18) . Furthermore, the postexercise glycogen values for the CHO-Pro-Fat and CHO trials were nearly identical, and the comparison between these two trials was the most important measurement in the present study.
A strength of the present study was the provision to each of the subjects in each trial of prepackaged diets that were isoenergetic to the subjects' habitual diet. We also controlled for 24-h energy intake by providing complimentary blinded supplements later in the day to ensure that the macronutrient composition over the 24-h period was consistent. This is important to examine the true effect of the timing of macronutrient provision not confounded by supplemental energy. A practical advantage of this approach is that we have found that women and those on restricted energy intakes are reluctant to consume additional energy. Another advantage of combination postexercise supplements is that they provide ''balanced'' macronutrients. For example, if one were to give a 1 g/kg CHO drink after exercise at t ϭ 0 and ϩ1 h to a woman weighing 60 kg, the energy content would be 480 kcal. With an energy intake of ϳ2,000 kcal, this would amount to ϳ25% of daily intake as a simple sugar. If this were part of a habitual diet, it might limit intake of vitamins, calcium, iron, and other minerals (25) that may be of particular concern for the female athlete (7, 12) . Furthermore, habitual endurance training increases protein requirements for male (14, 23) and female (17) athletes.
Our group has previously demonstrated that men, but not women, increased muscle glycogen concentration in response to an increase in dietary CHO from 60 to 75% of energy intake (24) . The results of the present study, however, were contradictory to our a priori hypothesis and did not show a difference between the genders in the rate of glycogen repletion. This is an important finding for female athletes, who may have a limited ability to supercompensate (24) . Whether the provision of supplements in the early postexercise period may permit glycogen supercompensation in women remains to be explored.
Our finding of a lower RER for the women in the present study has been demonstrated in three of our previous studies (17, 22, 24) and by others (2, 15, 10) . The RER finding indicates a greater lipid and lesser CHO oxidation for women during endurance exercise at 65% V O 2 peak . We found a trend toward a higher urea excretion on the exercise day for both men and women. This suggested a trend toward an increased whole body protein oxidation consequent to the exercise stress (17) . Contrary to our work in nutrient supplementation after resistance exercise (unpublished observations by B. D. Roy and M. A. Tarnopolsky), we did not demonstrate a suppression of urea excretion for the two supplement trials compared with the placebo trial. This may relate to differing metabolic situations after these types of activity. After resistance exercise, for example, we found that the reduction in urea excretion for the early supplement trial paralleled a decline in 3-methylhistidine excretion (indicative of lesser myofibrillar protein degradation) (18a). Although 3-methylhistidine was not measured in this study, it is unlikely that habitual endurance exercise at 65% V O 2 peak would be associated with myofibrillar protein breakdown (4) . Therefore, the trend toward an increased urea excretion on the exercise day was likely caused by an increased protein oxidation during (13, 17) and not after exercise.
In summary, we have demonstrated that, compared with a Pl drink, CHO and CHO-Pro-Fat supplements when given early after endurance exercise result in more rapid glycogen resynthesis rates. Importantly, this finding is true for both male and female athletes.
